Jenni Cryan

476 total citations
7 papers, 173 citations indexed

About

Jenni Cryan is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Jenni Cryan has authored 7 papers receiving a total of 173 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Hematology. Recurrent topics in Jenni Cryan's work include Protein Degradation and Inhibitors (3 papers), Ubiquitin and proteasome pathways (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Jenni Cryan is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), Ubiquitin and proteasome pathways (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Jenni Cryan collaborates with scholars based in United Kingdom, United States and China. Jenni Cryan's co-authors include Andrew B. Benowitz, Han Dai, Niall A. Anderson, John D. Harling, Robert J. Slack, Esther Fernández, Laura Ajram, Dawid Swieboda, Agnieszka Konopacka and Malcolm Begg and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, European Journal of Pharmacology and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Jenni Cryan

7 papers receiving 173 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jenni Cryan United Kingdom	5	140	90	32	28	18	7	173
Sonia C. Maggio United States	6	267 1.9×	77 0.9×	19 0.6×	47 1.7×	12 0.7×	7	297
Michael Boice United States	5	173 1.2×	33 0.4×	24 0.8×	28 1.0×	11 0.6×	6	237
Karin H. Herbschleb United Kingdom	6	126 0.9×	79 0.9×	7 0.2×	46 1.6×	15 0.8×	10	173
M. Jevric Serbia	5	40 0.3×	48 0.5×	23 0.7×	9 0.3×	16 0.9×	12	111
Tomoko Asatsuma‐Okumura Japan	6	244 1.7×	77 0.9×	11 0.3×	133 4.8×	11 0.6×	9	294
Helen X Chen United States	6	68 0.5×	71 0.8×	21 0.7×	21 0.8×	19 1.1×	8	127
Hoda Metwally United States	7	292 2.1×	148 1.6×	8 0.3×	92 3.3×	49 2.7×	10	324
Ashleigh Parkin Australia	7	83 0.6×	66 0.7×	28 0.9×	4 0.1×	15 0.8×	7	144
Valentina Vurchio Italy	5	86 0.6×	42 0.5×	15 0.5×	22 0.8×	17 0.9×	12	133
Montserrat Pérez-Salvia Spain	5	251 1.8×	56 0.6×	8 0.3×	64 2.3×	15 0.8×	6	276

Countries citing papers authored by Jenni Cryan

Since Specialization

Citations

This map shows the geographic impact of Jenni Cryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenni Cryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenni Cryan more than expected).

Fields of papers citing papers by Jenni Cryan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenni Cryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenni Cryan. The network helps show where Jenni Cryan may publish in the future.

Co-authorship network of co-authors of Jenni Cryan

This figure shows the co-authorship network connecting the top 25 collaborators of Jenni Cryan. A scholar is included among the top collaborators of Jenni Cryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenni Cryan. Jenni Cryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Stevens, Rebecca, Jenni Cryan, Peter Stacey, et al.. (2024). Expanding the reaction toolbox for nanoscale direct-to-biology PROTAC synthesis and biological evaluation. RSC Medicinal Chemistry. 16(3). 1141–1150. 8 indexed citations

2.

Chung, Chun‐wa, Han Dai, Esther Fernández, et al.. (2020). Structural Insights into PROTAC-Mediated Degradation of Bcl-xL. ACS Chemical Biology. 15(9). 2316–2323. 67 indexed citations

3.

Anderson, Niall A., et al.. (2020). Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs. Bioorganic & Medicinal Chemistry Letters. 30(9). 127106–127106. 50 indexed citations

4.

Ajram, Laura, Malcolm Begg, Robert J. Slack, et al.. (2014). Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists. European Journal of Pharmacology. 729. 75–85. 40 indexed citations

5.

Taylor, S., James R. Gray, Robert Willis, et al.. (2012). The utility of pharmacokinetic–pharmacodynamic modeling in the discovery and optimization of selective S1P₁agonists. Xenobiotica. 42(7). 671–686. 4 indexed citations

6.

Burbidge, Stephen A., et al.. (2000). Modulation of KCNQ potassium channels by retigabine. Figshare. 1 indexed citations

7.

Dumont, Francis J., Song Lin, Jenni Cryan, et al.. (1996). Mixed agonist/antagonist activity of an FK-506-related immunosuppressant: biological and biochemical characterization.. Journal of Pharmacology and Experimental Therapeutics. 276(3). 1078–1088. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact